SETAC Globe - Environmental Quality Through Science
2 November 2017
Volume 18 Issue 11

Return to the Globe

Endocrine Disruptor Testing and Risk Assessment Interest Group Tackles Hot New Topics

Annegaaike Leopold, Calidris Environment BV, and Heiko L. Schoenfuss, St. Cloud State University

The Endocrine Disruptor Testing and Risk Assessment Interest Group (EDTRA IG) has five new and active members of the Steering Committee, who have worked with the group to line up interesting and state-of-the-art sessions at the upcoming SETAC meetings in Minneapolis and Rome. There are a number of endocrine-related sessions at the SETAC North America 38th Annual Meeting this November in Minneapolis, Minnesota, that you will not want to miss. We would also like to personally invite you to send in papers and posters to our two EDTRA-sponsored sessions for the SETAC Europe 28th Annual Meeting, which will be held from 13–17 May 2018 in Rome, Italy.

We warmly welcome you to join the EDTRA IG meeting at SETAC Minneapolis, which will be held at 5:30 p.m. on Tuesday, 14 November, in room M100 J (after the plenary presentation has ended). During this open meeting, we will discuss our current and upcoming activities. The meeting will feature a presentation by long-time SETAC member and past president of the SETAC World Council, Patrick Guiney. Guiney will review a case study of tributyltin (TBT) – a non-conventional endocrine disruptor. In addition, participants will be updated on recent developments in the endocrine regulatory landscape in Europe. The IG meeting is open to all.

In addition to the EDTRA IG meeting, SETAC North America will feature an EDTRA-sponsored, two-part session (Monday and Wednesday afternoons) on efforts to restore the North American Great Lakes in the context of contaminants of emerging concern, which include many endocrine active compounds. Conference attendees interested in endocrine active substances and endocrine disruptors may also consider attending the session titled “Aquatic Toxicology and Ecology-Endocrine Disruptors,” chaired by Michael Horning and Jennifer Olker, on Monday morning. Lastly, a Thursday morning session organized by Vance Trudeau and Cheryl Rosenfeld will explore the emerging concept of neuroendocrine disruption. There is plenty to choose from at SETAC North America for scientists interested in endocrine active substances and endocrine disruption.

In the meantime, preparations are fully underway for SETAC Rome. Another interesting and dynamic presentation is planned during the EDTRA IG meeting. Details will be announced in the coming months and presented on the EDTRA IG website and in the conference program. SETAC Rome will also feature two EDTRA IG-sponsored sessions. In one session, we will explore exciting new methods to address limitations in the assessment of endocrine disruption effects, both in humans and wildlife. We will be encouraging speakers to incorporate the Adverse Outcome Pathway (AOP) concept to inform the knowledge gaps that are being highlighted in the presentations. The other endocrine session provides an opportunity to present and discuss aspects pertaining to the harmonization of assessment approaches for endocrine disruptors with professionals from industry, academia, regulatory authorities and policy makers.

You are encouraged to go to the EDTRA IG website at to learn more about our interest group and find announcements for upcoming activities. We look forward to welcoming many of you to our meetings and sessions in Minneapolis and Rome.

Authors’ contact information: and

Return to the Globe

Contact SETAC Globe
Contact the SETAC Europe office
Contact the SETAC Europe office